Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of breast cancer therapeutics.
Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
Immune Design is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body’s immune system to fight disease.
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
PhaseRx is a biopharmaceutical company developing a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children.
KinDex was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease.
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
ApoGen Biotechnologies is developing novel oncology therapeutics targeting the key drivers of mutation and cancer genomic evolution to overcome drug resistance.
Proniras is a preclinical-stage biotechnology company developing drugs for orphan neurological diseases.
Icosavax is a biotechnology company that develops vaccines against infectious diseases.